Found: 18
Select item for more details and to access through your institution.
A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00745
- By:
- Publication type:
- Article
ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.
- Published in:
- 2018
- By:
- Publication type:
- journal article
(2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125323
- By:
- Publication type:
- Article
Characterization of an endoplasmic reticulum stress‐related signature to evaluate immune features and predict prognosis in glioma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 8, p. 3870, doi. 10.1111/jcmm.16321
- By:
- Publication type:
- Article
A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 7, p. 3807, doi. 10.1111/jcmm.14938
- By:
- Publication type:
- Article
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
AID recruits the RNA exosome to degrade HIV‐1 nascent transcripts through interaction with the Tat‐P‐TEFb‐TAR RNP complex.
- Published in:
- FEBS Letters, 2018, v. 592, n. 2, p. 284, doi. 10.1002/1873-3468.12954
- By:
- Publication type:
- Article
TGF-β triggers HBV cccDNA degradation through AID-dependent deamination.
- Published in:
- FEBS Letters, 2016, v. 590, n. 3, p. 419, doi. 10.1002/1873-3468.12058
- By:
- Publication type:
- Article
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05667-4
- By:
- Publication type:
- Article
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1113, doi. 10.1093/neuonc/noac033
- By:
- Publication type:
- Article
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4181, doi. 10.2147/OTT.S198762
- By:
- Publication type:
- Article
Ependymoblastoma with cystic change in a child.
- Published in:
- Journal of Neurosurgery, 2014, p. 658, doi. 10.3171/2014.3.PEDS13405
- By:
- Publication type:
- Article
LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.569584
- By:
- Publication type:
- Article
Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.581197
- By:
- Publication type:
- Article
Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01059
- By:
- Publication type:
- Article
Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 11755, doi. 10.2147/OTT.S275452
- By:
- Publication type:
- Article
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 1129, doi. 10.2147/OTT.S237162
- By:
- Publication type:
- Article
ARL3 is downregulated and acts as a prognostic biomarker in glioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article